← Leaderboards
Lewis C Cantley
Beth Israel Deaconess Medical Center
$35,988,650
Attributed
$35,988,650
Total exposure
17
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$68,237,292 · 20
By mechanism
P01$30,676,712 · 9
R01$11,619,747 · 4
U54$10,218,853 · 1
R35$9,179,621 · 1
R37$3,823,844 · 1
P50$2,701,323 · 3
Top collaborators
- Claudia Fischbach5 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Gerburg M Wulf$4,301,499
- Mark A Herman$6,685,137
- Rajiv R Ratan$2,742,688
- Alex Toker$16,651,718
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsSignal TransductionCell GrowthMalignant NeoplasmsTumorGrowthSignal PathwayProteinsCellsPhosphotransferasesResponsePhosphatidylinositolsGrantProtein KinaseMutationGeneticMediatingIn VivoBiochemicalPhosphorylationBinding (Molecular Function)TissuesBaseClinical Trials
Grant awards (105)
Role of Phosphoinositides and Protein Kinases in the control of Cancer Metabolism$1,062,381
R35 · FY2025 · CA · contact PI
Role of Phosphoinositides and Protein Kinases in the control of Cancer Metabolism$1,052,496
R35 · FY2024 · CA · contact PI
Phosphoinositides and Cancer Metabolism$993,256
R35 · FY2022 · CA · contact PI
Phosphoinositides and Cancer Metabolism$1,017,000
R35 · FY2021 · CA · contact PI
Center on the Physics of Cancer Metabolism$2,097,676
U54 · FY2020 · CA
Phosphoinositides and Cancer Metabolism$1,016,999
R35 · FY2020 · CA · contact PI
Center on the Physics of Cancer Metabolism$2,006,322
U54 · FY2019 · CA
Phosphoinositides and Cancer Metabolism$986,489
R35 · FY2019 · CA · contact PI
Center on the Physics of Cancer Metabolism$2,021,161
U54 · FY2018 · CA
Phosphoinositides and Cancer Metabolism$1,017,000
R35 · FY2018 · CA · contact PI
Center on the Physics of Cancer Metabolism$1,985,808
U54 · FY2017 · CA
Phosphoinositides and Cancer Metabolism$1,017,000
R35 · FY2017 · CA · contact PI
Center on the Physics of Cancer Metabolism$2,107,886
U54 · FY2016 · CA
Phosphoinositides and Cancer Metabolism$1,017,000
R35 · FY2016 · CA · contact PI
The Role of PI3K in Growth Regulation$491,550
R01 · FY2016 · GM · contact PI
LKB1/AMPK signaling and Peutz-Jeghers syndrome$205,457
P01 · FY2016 · CA · contact PI
The Role of PI3K in Growth Regulation$491,550
R01 · FY2015 · GM · contact PI
MEK AND PI3K INHIBITION IN THE REGULATION OF PANCREATIC CANCER METABOLISM$467,774
P01 · FY2015 · CA · contact PI
LKB1/AMPK signaling and Peutz-Jeghers syndrome$205,855
P01 · FY2015 · CA · contact PI
The Role of PI3K in Growth Regulation$491,550
R01 · FY2014 · GM · contact PI
MEK AND PI3K INHIBITION IN THE REGULATION OF PANCREATIC CANCER METABOLISM$411,122
P01 · FY2014 · CA · contact PI
LKB1/AMPK signaling and Peutz-Jeghers syndrome$198,305
P01 · FY2014 · CA · contact PI
The Role of PI3K in Growth Regulation$367,815
R01 · FY2013 · GM · contact PI
MEK AND PI3K INHIBITION IN THE REGULATION OF PANCREATIC CANCER METABOLISM$334,731
P01 · FY2013 · CA · contact PI
LKB1/AMPK signaling and Peutz-Jeghers syndrome$192,623
P01 · FY2013 · CA · contact PI
The Role of PI3K in Growth Regulation$127,000
R01 · FY2013 · GM · contact PI
PHOSPHATDYLINOSITOL-3-P AND GROWTH REGULATION$523,315
R01 · FY2012 · GM · contact PI
MEK AND PI3K INHIBITION IN THE REGULATION OF PANCREATIC CANCER METABOLISM$437,090
P01 · FY2012 · CA · contact PI
Protein Kinase Signaling Pathways$366,557
R01 · FY2012 · GM · contact PI
LKB1/AMPK signaling and Peutz-Jeghers syndrome$213,704
P01 · FY2012 · CA · contact PI
The Role of PTEN and the PI3K Pathway in Prostate Cancer$2,037,021
P01 · FY2011 · CA · contact PI
PHOSPHATDYLINOSITOL-3-P AND GROWTH REGULATION$523,315
R01 · FY2011 · GM · contact PI
MEK AND PI3K INHIBITION IN THE REGULATION OF PANCREATIC CANCER METABOLISM$460,342
P01 · FY2011 · CA · contact PI
The role of Phosphoinositide 3 Kinase isoforms in Prostate Cancer$454,774
P01 · FY2011 · CA · contact PI
LKB1/AMPK Signaling and Peutz-Jeghers Syndrome$454,494
P01 · FY2011 · CA · contact PI
Protein Kinase Signaling Pathways$366,557
R01 · FY2011 · GM · contact PI
Mass Spectrometry Core$160,668
P01 · FY2011 · CA · contact PI
The Role of PTEN and the PI3K Pathway in Prostate Cancer$2,107,760
P01 · FY2010 · CA · contact PI
PHOSPHATDYLINOSITOL-3-P AND GROWTH REGULATION$528,160
R01 · FY2010 · GM · contact PI
The role of Phosphoinositide 3 Kinase isoforms in Prostate Cancer$471,840
P01 · FY2010 · CA · contact PI
LKB1/AMPK Signaling and Peutz-Jeghers Syndrome$469,609
P01 · FY2010 · CA · contact PI
The RAS and P13K Pathways in Pancreatic Adenocarcinoma$393,191
P01 · FY2010 · CA · contact PI
Protein Kinase Signaling Pathways$370,260
R01 · FY2010 · GM · contact PI
Mass Spectrometry Core$166,153
P01 · FY2010 · CA · contact PI
The Role of PTEN and the PI3K Pathway in Prostate Cancer$2,074,252
P01 · FY2009 · CA · contact PI
PHOSPHATDYLINOSITOL-3-P AND GROWTH REGULATION$514,944
R01 · FY2009 · GM · contact PI
The role of Phosphoinositide 3 Kinase isoforms in Prostate Cancer$465,637
P01 · FY2009 · CA · contact PI
LKB1/AMPK Signaling and Peutz-Jeghers Syndrome$461,147
P01 · FY2009 · CA · contact PI
The RAS and P13K Pathways in Pancreatic Adenocarcinoma$380,488
P01 · FY2009 · CA · contact PI
Protein Kinase Signaling Pathways$374,000
R01 · FY2009 · GM · contact PI
Mass Spectrometry Core$163,288
P01 · FY2009 · CA · contact PI
HUMAN PYRUVATE KINASE ISOFORM 2 BINDING$17,192
P41 · FY2009 · RR · contact PI
The Role of PTEN and the PI3K Pathway in Prostate Cancer$2,026,408
P01 · FY2008 · CA · contact PI
LKB1/AMPK Signaling and Peutz-Jeghers Syndrome$457,700
P01 · FY2008 · CA · contact PI
The role of Phosphoinositide 3 Kinase isoforms in Prostate Cancer$455,968
P01 · FY2008 · CA · contact PI
PHOSPHATDYLINOSITOL-3-P AND GROWTH REGULATION$451,821
R37 · FY2008 · GM · contact PI
Characterization of Phosphatidylinositol Kinases$375,056
R01 · FY2008 · GM · contact PI
The RAS and P13K Pathways in Pancreatic Adenocarcinoma$369,799
P01 · FY2008 · CA · contact PI
Protein Kinase Signaling Pathways$342,530
R01 · FY2008 · GM · contact PI
Mass Spectrometry Core$162,204
P01 · FY2008 · CA · contact PI
The Role of PTEN and the PI3K Pathway in Prostate Cancer$2,125,652
P01 · FY2007 · CA · contact PI
LKB1/AMPK Signaling and Peutz-Jeghers Syndrome$463,681
P01 · FY2007 · CA · contact PI
The role of Phosphoinositide 3 Kinase isoforms in Prostate Cancer$459,197
P01 · FY2007 · CA · contact PI
PHOSPHATDYLINOSITOL-3-P AND GROWTH REGULATION$452,872
R37 · FY2007 · GM · contact PI
Characterization of Phosphatidylinositol Kinases$375,100
R01 · FY2007 · GM · contact PI
The RAS and P13K Pathways in Pancreatic Adenocarcinoma$366,179
P01 · FY2007 · CA · contact PI
Protein Kinase Signaling Pathways$342,530
R01 · FY2007 · GM · contact PI
Mass Spectrometry Core$157,678
P01 · FY2007 · CA · contact PI
Administrative Core$83,537
P01 · FY2007 · CA · contact PI
PHOSPHATDYLINOSITOL-3-P AND GROWTH REGULATION$453,040
R37 · FY2006 · GM · contact PI
Characterization of Phosphatidylinositol Kinases$375,150
R01 · FY2006 · GM · contact PI
Protein Kinase Signaling Pathways$352,760
R01 · FY2006 · GM · contact PI
The RAS and P13K Pathways in Pancreatic Adenocarcinoma$326,760
P01 · FY2006 · CA · contact PI
THE ROLE OF PTEN AND THE PI3K PATHWAY IN PROSTATE CANCER$150,910
P01 · FY2006 · CA · contact PI
THE ROLE OF PTEN AND THE PI3K PATHWAY IN PROSTATE CANCER$2,008,584
P01 · FY2005 · CA
PHOSPHATDYLINOSITOL-3-P AND GROWTH REGULATION$450,529
R37 · FY2005 · GM
Characterization of Phosphatidylinositol Kinases$373,087
R01 · FY2005 · GM
Protein Kinase Signaling Pathways$361,250
R01 · FY2005 · GM
THE ROLE OF PTEN AND THE PI3K PATHWAY IN PROSTATE CANCER$1,963,703
P01 · FY2004 · CA
PHOSPHATDYLINOSITOL-3-P AND GROWTH REGULATION$437,507
R37 · FY2004 · GM
Protein Kinase Signaling Pathways$340,000
R01 · FY2004 · GM
THE ROLE OF PTEN AND THE PI3K PATHWAY IN PROSTATE CANCER$1,905,713
P01 · FY2003 · CA
PHOSPHATDYLINOSITOL-3-P AND GROWTH REGULATION$410,884
R37 · FY2003 · GM
CHARACTERIZATION OF PHOSPHATIDYLINOSITOL KINASES$353,190
R01 · FY2003 · GM
Protein Kinase Signaling Pathways$340,000
R01 · FY2003 · GM
THE ROLE OF PTEN AND THE PI3K PATHWAY IN PROSTATE CANCER$1,853,371
P01 · FY2002 · CA
PHOSPHATDYLINOSITOL-3-P AND GROWTH REGULATION$398,916
R37 · FY2002 · GM
CHARACTERIZATION OF PHOSPHATIDYLINOSITOL KINASES$343,004
R01 · FY2002 · GM
Protein Kinase Signaling Pathways$340,000
R01 · FY2002 · GM
FUNCTION OF THE ATAXIA TELANGIECTASIA GENE PRODUCT$206,331
R01 · FY2002 · GM
PI3K regulatory subunits and prostate cancer$103,677
P01 · FY2002 · CA
THE ROLE OF PTEN AND THE PI3K PATHWAY IN PROSTATE CANCER$1,848,666
P01 · FY2001 · CA
SCOR IN MOLECULAR MEDICINE AND ATHEROSCLEROSIS$1,007,540
P50 · FY2001 · HL
PHOSPHATDYLINOSITOL-3-P AND GROWTH REGULATION$388,967
R37 · FY2001 · GM
Protein Kinase Signaling Pathways$340,000
R01 · FY2001 · GM
CHARACTERIZATION OF PHOSPHATIDYLINOSITOL KINASES$333,113
R01 · FY2001 · GM
PROTEIN TYROSINE KINASE SIGNALING PATHWAYS IN VASCULAR CELLS$274,326
P50 · FY2001 · HL
CORE--PROTEIN EXPRESSION$274,326
P50 · FY2001 · HL
PI3K regulatory subunits and prostate cancer$0
P01 · FY2001 · CA
SCOR IN MOLECULAR MEDICINE AND ATHEROSCLEROSIS$920,209
P50 · FY2000 · HL
PHOSPHATDYLINOSITOL-3-P AND GROWTH REGULATION$379,308
R37 · FY2000 · GM
CHARACTERIZATION OF PHOSPHATIDYLINOSITOL KINASES$348,820
R01 · FY2000 · GM
PROTEIN KINASE SIGNALING PATHWAYS$241,253
R01 · FY2000 · GM
CORE--PROTEIN EXPRESSION$112,461
P50 · FY2000 · HL
PROTEIN TYROSINE KINASE SIGNALING PATHWAYS IN VASCULAR CELLS$112,461
P50 · FY2000 · HL